Based on a review of the treatment of SARS and MERS, it is generally believed that the use of hormones may have less benefit, especially in high doses and long courses, and that their disadvantages outweigh their benefits and are not recommended. Some scholars’ experience comes from the treatment of influenza, and through a comprehensive analysis of a large sample, it is believed that influenza patients may have increased morbidity and mortality if hormones are used. Based on this philosophy, some scholars believe that hormones should not be used in novel coronavirus pneumonia either. In practice, we learned that some hospitals are still using high doses of hormones, which is not desirable. In addition, there are many experts who believe that the use of small doses and short courses of hormones can help avoid the occurrence of heavy cases and alleviate symptoms when the fever is high or the disease is progressing rapidly, if the timing is well chosen. There is still a clinical controversy. Most hospitals are choosing a good time to use small doses and short courses of treatment do receive results as well. If it is under the premise of choosing a good timing, the benefits of using small doses should outweigh the disadvantages. Content source: Dr. You Lai